Skip to main content
. Author manuscript; available in PMC: 2015 Dec 1.
Published in final edited form as: Cancer Res. 2014 Oct 8;74(23):7024–7036. doi: 10.1158/0008-5472.CAN-14-1346

Figure 4. In Vivo Effects of Cyclopamine and RT.

Figure 4

A. Figure describing location of orthotopic FOTM tumor implanted in athymic nude mouse. B. Schema describing cyclopamine and/or RT dose and duration for animal tumor growth studies. Tumor growth for orthotopically implanted FOTM HN11 (C) and TU167 (D) parental tumors was assessed at 28 days post-treatment initiation.